These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17768685)

  • 1. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
    Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
    Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of MMPPs and TIMP and invasiveness in pituitary adenomas].
    Wang J; Liu YS
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):647-50. PubMed ID: 16114548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas.
    Liu W; Matsumoto Y; Okada M; Miyake K; Kunishio K; Kawai N; Tamiya T; Nagao S
    J Med Invest; 2005 Aug; 52(3-4):151-8. PubMed ID: 16167532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of matrix metalloproteinase 9 in pituitary tumor behavior.
    Turner HE; Nagy Z; Esiri MM; Harris AL; Wass JA
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2931-5. PubMed ID: 10946906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion.
    Mao JH; Guo H; Si N; Qiu L; Guo LF; Sun ZS; Xiang Y; Yang XH; Zhao WG; Zhang WC
    Genet Mol Res; 2015 Dec; 14(4):17091-8. PubMed ID: 26681056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas.
    Gültekin GD; Çabuk B; Vural Ç; Ceylan S
    J Clin Neurosci; 2015 Aug; 22(8):1282-7. PubMed ID: 26071077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.
    Hussaini IM; Trotter C; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Agi CU; Redpath GT; Fang Z; Leung GK; Lopes MB; Laws ER
    Am J Pathol; 2007 Jan; 170(1):356-65. PubMed ID: 17200207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas.
    Liu B; Pang B; Wang Q; Yang S; Gao T; Ding Q; Liu H; Yang Y; Fan H; Zhang R; Xin T; Xu G; Pang Q
    Hum Pathol; 2017 Aug; 66():101-107. PubMed ID: 28666925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas.
    Liu W; Kunishio K; Matsumoto Y; Okada M; Nagao S
    J Clin Neurosci; 2005 Sep; 12(7):791-4. PubMed ID: 16198918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
    Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
    Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.
    Liu HY; Gu WJ; Wang CZ; Ji XJ; Mu YM
    Medicine (Baltimore); 2016 Jun; 95(24):e3904. PubMed ID: 27310993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
    He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
    Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressions of Matrix Metalloproteinases-9 and Tissue Inhibitor of Metalloproteinase-1 in Pituitary Adenomas and Their Relationships with Prognosis.
    Guo H; Sun Z; Wei J; Xiang Y; Qiu L; Guo L; Zhao W; Xu Z; Mao J
    Cancer Biother Radiopharm; 2019 Feb; 34(1):1-6. PubMed ID: 30676069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor.
    Sun B; Liu X; Yang Y; Dai C; Li Y; Jiao Y; Wei Z; Yao Y; Feng M; Bao X; Deng K; Wang N; Wang R
    J Mol Neurosci; 2016 Jan; 58(1):137-44. PubMed ID: 26676407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.
    Wang M; Zhang H; Heng X; Pang Q; Sun A
    Med Sci Monit; 2015 May; 21():1256-60. PubMed ID: 25934796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
    Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
    J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
    Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
    J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
    Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
    J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.
    Mendes GA; Haag T; Trott G; Rech CGSL; Ferreira NP; Oliveira MC; Kohek MB; Pereira-Lima JFS
    Braz J Med Biol Res; 2017 Dec; 51(2):e6808. PubMed ID: 29267504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.